-transparent.png){kind=logo}
The use of methadone in the treatment of heroin addiction continues to be controversial. Propoxyphene napsylate (Darvon N(R)) is a possible alternative and a pilot study was conducted to test its acceptability, safety and clinical efficacy in treating long term, "multi-relapse" heroin addicts. Findings indicate that propoxyphene napsylate suppresses many of the symptoms associated with opioid withdrawal phenomena. It should be viewed as a very promising therapeutic tool to be used in conjunction with psychological counseling and socio-vocational rehabilitation in detoxification and maintenance therapy for heroin or methadone addiction.
Related Publications
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
November 1973,
JAMA,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
January 1974,
Journal of the National Medical Association,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
April 1982,
NIDA research monograph,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
January 1979,
NIDA research monograph,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
February 1977,
Archives of general psychiatry,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
April 1982,
NIDA research monograph,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
January 1981,
Psychopharmacology,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
August 1981,
Drug and alcohol dependence,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
November 1976,
Annals of internal medicine,
D S Inaba, and
G R Gay, and
C A Whitehead, and
J A Newmeyer, and
D Bergin
January 1973,
Annual review of medicine,
